Quality of care for secondary cardiovascular disease prevention in 2009–2017: population-wide cohort study of antiplatelet therapy use in Scotland

BACKGROUND: Antiplatelet therapy (APT) can substantially reduce the risk of further vascular events in individuals with established atherosclerotic cardiovascular disease (ASCVD). However, knowledge regarding the extent and determinants of APT use is limited. OBJECTIVES: Estimate the extent and iden...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Qual Saf
Autors principals: Thalmann, Inna, Preiss, David, Schlackow, Iryna, Gray, Alastair, Mihaylova, Borislava
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2023
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7616486/
https://ncbi.nlm.nih.gov/pubmed/37775268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjqs-2023-016520
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars